• Title/Summary/Keyword: 항암화학 요법

Search Result 668, Processing Time 0.028 seconds

The Relationships among Chemotherapy-Induced Nausea and Vomiting (CINV), Non-Pharmacological Coping Methods, and Nutritional Status in Patients with Gynecologic Cancer (부인암 환자의 항암화학요법으로 인한 오심과 구토, 비약물적 대처방법과 영양상태간의 관계)

  • Lee, Haerim;ChoiKwon, Smi
    • Journal of Korean Academy of Nursing
    • /
    • v.47 no.6
    • /
    • pp.731-743
    • /
    • 2017
  • Purpose: Chemotherapy-induced nausea and vomiting (CINV) can cause severe malnutrition. However, relationships between CINV levels, non-pharmacological coping methods, and nutritional status of female cancer patients have rarely been investigated. Therefore, this study aimed to analyze their relationships in gynecologic cancer patients. Methods: Participants receiving a highly and moderately emetogenic chemotherapy were recruited. The level of CINV was assessed using a numeric rating scale. Coping methods were determined using multiple-choice self-report questionnaires and categorized into seven types for statistical analysis. Nutritional status was evaluated using biochemical and anthropometric parameters. Results: Among all the 485 patients, 200 eligible inpatients were included. Despite the administration of prophylactic antiemetics, 157 patients (78.5%) still experienced CINV, and several used nonmedically recommended coping methods, such as just enduring the symptom or rejecting food intake. A total of 181 patients (90.5%) had nutritional disorders. Although the level of CINV was indirectly related to the occurrence of nutritional disorders, patients who rejected food (${\beta}=1.57$, p=.023) and did not use physical measures (${\beta}=-1.23$, p=.041) as coping methods were under the high risk of nutritional disorders. Conclusion: Korean gynecologic cancer patients had high levels of CINV and were at high risk of nutritional disorders, which may be related to the use of nonscientific coping methods, possibly due to cultural backgrounds and lack of proper nutritional program. Therefore, developing a culturally appropriate educational program for the cancer patients with CINV is urgently needed.

Acupuncture attenuates bladder hyperactivity in the cyclophosphamide-induced cystitis in rats (침 자극의 씨클로포스파미드로 유발한 백서 방광염 모델에서 방광의 과활동성에 대한 억제효과)

  • Chae, Youn-Byoung;Rho, Hyun;Park, Hi-Joon;Lee, Sun-Ju;Lee, Hye-Jung
    • Korean Journal of Acupuncture
    • /
    • v.23 no.3
    • /
    • pp.73-80
    • /
    • 2006
  • 목 적 : 씨클로포스파미드(Cyclophosphamide, CP)는 많은 종양 질환에서 단독 혹은 다른 화학요법과 함께 사용되는 항암제이다. CP의 독성과 부작용으로 출혈성 방광염이 많은 문제를 일으키고 있다. CP로 유도된 방광염 모델은 하부요로의 통증질환을 이해하기 위한 내장성 통증의 주요한 모델로 사용되고 있다. 본 연구는 암컷 백서에서 CP로 유도된 방광의 과활동성에 대한 침의 효과를 관찰하기 위해 요류역학검사를 수행하였다. 방 법 : CP (200 mg/kg) 투여 18시간 후에, 지속적 생리식염수 관류 (분당 0.04 ml) 로 방광내압 측정을 통해 방광기능을 평가하였다. 관류 2시간 이후부터, 위중/곤륜 100 Hz, 위중/곤륜 2 Hz, 족삼리/삼음교 100 Hz, 족삼리/삼음교 2Hz 전침 자극을 하여 자침 전후의 방광수축간격(intercontraction interval, ICI)을 비교하였다. 결 과 : 방광내압 측정하는 동안, 방광수축간격은 CP로 유도된 방광염 모델에서 정상군에서 보다 유의하게 짧았다. CP로 유도된 방광염 모델에서, 위중/곤륜 100Hz 전침 자극은 자침 전보다 통계적으로 유의하게 $40.6\;{\pm}\;10.9\;%$ 증가시켰고, 2Hz 전침 자극은 자침 전보다 현저하게 $22.1\;{\pm}\;13.7\;%$ 증가시켰다. 반면에, 족삼리/삼음교 전침 자극은 100Hz, 강 2Hz 전침 자극 각각 $13.7\;{\pm}\;8.1\;%,\;8.7\;{\pm}\;4.5\;%$ 약간 증가시켰다. 결 론 : 족태양방광경의 경혈에 100Hz 전칩 자극을 하여 CP로 유도된 방광의 과활동성을 억제하였다. 이러한 결과는 침 자극으로 CP로 유도된 혹은 다른 종류의 방광염을 치료하는데 효과적일 것임을 시사한다. 또한, 특정 경락의 경혈과 해당 장부의 질환의 치료에 연관성을 보여준다.

  • PDF

A case of Primary Malignant Fibrous Histiocytoma of the Diaphragm (횡경막에 발생한 악성 섬유종 조직구종 1예)

  • Shim, Jaejun;Cho, Yongseon;Kim, Hyun-Sook;Choi, Hye-Sook;Choi, Cheon Woong;Yoo, Jee Hong;Kang, Hong Mo;Yang, Moon Ho
    • Tuberculosis and Respiratory Diseases
    • /
    • v.54 no.6
    • /
    • pp.645-650
    • /
    • 2003
  • A malignant fibrous histiocytoma (MFH) is a major subset of soft tissue sarcomas, which occurs principally on the extremities or in the retroperitoneum, as well as on the head and neck of elderly patient. However, it is an extremely rare event when a MFH occurs primarily in the diaphragm of a young people. A 25-year-old woman visited our hospital complaining of right chest pain. The chest X-ray showed a diaphragmatic mass. An exploratory thoracotomic biopsy revealed a primary MFH of the diaphragm. The patient was treated with combined chemotherapy consisting of ifosfamide and doxorubicin. A partial response was seen after 6 cycles of chemotherapy. However, she died of brain metastasis 12 months after the diagnosis.

Nutritional Risk in Oncology Outpatients Receiving Chemotherapy (외래에서 항암화학요법을 받는 암환자들의 영양불량 위험도 연구)

  • Kim, Won-Gyoung;Park, Mi-Sun;Lee, Young-Hee;Heo, Dae-Seog
    • Korean Journal of Community Nutrition
    • /
    • v.13 no.4
    • /
    • pp.573-581
    • /
    • 2008
  • Although it is well known that cancer patients suffer from malnutrition, there are few published studies on malnutrition in outpatients receiving chemotherapy in Korea. This study aimed to evaluate nutritional risk in oncology outpatients receiving chemotherapy and to show the baseline data to set up nutritional management programs for cancer patients. This is a retrospective observational analysis on 1,962 patients referred for nutritional education before or during chemotherapy at Seoul National University Hospital Cancer Center from January 2006 to May 2007. According to a malnutrition screening tool, the proportion of patients having malnutrition risk was 23.0%. In the case of upper gastrointestinal cancer, more than 50% of patients were assessed as being at the risk of malnutrition. They showed more than 7% weight loss compared to their usual body weight and poor oral intake; energy intake was less than 100% of Basal Energy Expenditure(BEE) and protein intake was less than or equal to 0.77 g/kg/d. However, only 6.3% of breast cancer patients had risk of malnutrition and their oral intake was better; energy intake was 121% of BEE, and protein intake was 0.90 g/kg/d. Outpatients receiving chemotherapy had different nutritional risk depending on their cancer site. Nutritional management program should be conducted differently, depending on the cancer site and upper gastrointestinal cancer patients at high risk of malnutrition should basically have nutritional assessment and intervention.

The Therapeutic Efficacy of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis (항암화학요법 유발 말초신경병증에 대한 침치료의 효과 : 체계적 문헌고찰 및 메타 분석)

  • Kim, Eun Hye;Yoon, Jee-Hyun;Lee, Jee Young;Yoon, Seong Woo
    • The Journal of Internal Korean Medicine
    • /
    • v.41 no.3
    • /
    • pp.350-361
    • /
    • 2020
  • Objective: This study aimed to report the therapeutic effect of acupuncture on chemotherapy-induced peripheral neuropathy (CIPN). Methods: The articles were sourced from databases including PubMed, EMBASE, Cochrane Library, CNKI, CiNii, WHO ICTRP, JSOM, KMBASE, KISS, NDSL, and OASIS as of July 2019. The main search keywords were peripheral neuropathy and acupuncture, and only randomized controlled trials using acupuncture for therapeutic purposes were included. Cochrane's risk of bias was used to assess the risk of bias, and the Review Manager 5.3 program was used for meta-analysis. Results: Six studies with a total 394 participants were included. When combined treatment of acupuncture and usual care was compared with usual care alone, quality of life improved more significantly in the combination treatment group (SMD=-2.71, 95% CI: -5.01 to -0.41, P=0.02, I2=97%). The CIPN pain score was lower among the combination treatment group, but not to a significant degree (SMD=-2.55, 95% CI: -5.14 to 0.04, P<0.05, I2=98%). There were no severe side effects in any studies. Conclusion: Acupuncture combined with usual care may be considered to safely relieve CIPN pain and improve quality of life for cancer patients. However, as there are few randomized controlled trials studying the effect of acupuncture on CIPN, further well-designed research is needed.

A Case of Posttransplant Lymphoproliferative Disease Following Renal Transplantation in a Child (소아에서 신장 이식 후 발생한 Posttransplant Lymphoproliferative Disease 1례)

  • Jhang Won-Kyoung;Hahn Hye-Won;Lee Mee-Jeung;Ghim Thad-T.;Park Young-Seo
    • Childhood Kidney Diseases
    • /
    • v.7 no.2
    • /
    • pp.245-252
    • /
    • 2003
  • Posttransplant lymphoproliferative disease(PTLD) has emerged as a potential life-threatening complication of immunosuppressive therapy after organ transplantation. The occurrence of PTLD is usually associated with an Epstein-Barr virus(EBV) infection in patients who are treated by aggressive immunosuppressive therapy. PTLD is represented by diverse manifestations ranging from reactive lymphoid hyperplasia to high grade malignant lymphoma. This is a case report of a late PTLD in a child. The patient is a 14-year-old girl, who presented as malignant lymphoma 44 months after successful renal transplantation. There was no evidence of EBV infection. On bone marrow study, many neoplastic lymphoid cells were defected. Aggressive chemotherapy for PTLD had resulted in clinical remission. However the patient expired from uncontrolled sepsis and septic shock after 77 days.

  • PDF

The Effect of Banhasasim-tang in the Treatment of Chemotherapy-induced Symptoms: A Systematic Review (항암화학요법으로 인한 증상에 대한 반하사심탕의 효과 : 체계적 문헌고찰)

  • Ahn, Su-bin;Lee, Ga-young;Hwang, Hyeon-ho;Jeong, Min-jeong;Jang, In-soo
    • The Journal of Internal Korean Medicine
    • /
    • v.40 no.4
    • /
    • pp.663-674
    • /
    • 2019
  • Objective: The purpose of this study was to investigate (using a systematic review) the effect of Banhasasim-tang in the treatment of chemotherapy-induced symptoms. Method: A systematic review was conducted to identify the effect of Banhasasim-tang for chemotherapy-induced symptoms. Electronic databases were used, including such as PubMed, Cochrane, CNKI, Wanfang, CiNii, J-STAGE, NDSL, and OASIS. Among others, the main search terms included "cancer", "Banhasasim-tang", "Banxia Xiexin Tang", and "Hangeshashin-to". This study only included randomized controlled trials (RCTs). Results: A total of 14 RCTs were selected. They all identified the effect of Banhasasim-tang in the treatment of chemotherapy-induced symptoms such as nausea, vomiting, and diarrhea. In addition, five of the studies evaluated the preventive effect of Banhasasim-tang on the symptoms. Conclusion: An analysis of 14 RCTs showed that Banhasasim-tang for chemotherapy-induced symptoms might be effective not only for treatment but also for prevention. However, due to the low quality and number of the selected original articles, the significance of this conclusion is somewhat limited. It is hoped that more systematic and rigorous clinical trials will be conducted.

Korean Medical Treatment of Sequela Following Chemotherapy for Recurrent Ovarian Cancer after Hysterectomy: a Case Report (재발성 난소암 환자의 화학적 항암요법 후유증 치험 1례)

  • Baek, Ji-Won;Nam, Woo-Jin;Kim, Su-Na;Kong, Won-Ho;Park, Yeo-Bin;Park, Yun-Leong;Gong, Bok-Chul
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.32 no.2
    • /
    • pp.129-137
    • /
    • 2019
  • Objectives: Most of the time after chemotherapy for ovarian cancer, the immune system is getting even worse with reduction of whole blood cell. The purpose of this study is to report the effect of korean medical treatment on Sequela including pancytopenia after chemotherapy for recurrent ovarian cancer after hysterectomy. Methods: The patient having treated with hospital management from June 8th in 2017 until July 5th in 2017, participated. Her chief complaints were fatigue, tinnitus, dizziness, decreased appetite due to glossodynia and constipation. We diagnosed her as pancytopenia based on her whole blood test result. We treated the patient with acupuncture, herbal medicine, cupping and moxibustion. The efficacy of treatment was evaluated with Numerical Rating Scale (NRS) and blood test. Results: During hospitalization period, the symptoms including fatigue, tinnitus, dizziness, decreased appetite, constipation and pancytopenia were reduced. After discharging, we identified that her blood levels are maintained and ovarian cancer no longer recurred. Conclusions: To recover from Sequela including pancytopenia following chemotherapy for recurrent ovarian cancer after hysterectomy, Korean medical treatment is considered to be effective.

The Therapeutic Efficacy of Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis (항암화학요법 유발 말초신경병증에 대한 한약의 치료 효과: 체계적 문헌고찰 및 메타 분석)

  • Kim, Eun Hye;Yoon, Jee-hyun;Lee, Jee Young;Yoon, Seong Woo
    • Journal of Korean Traditional Oncology
    • /
    • v.25 no.2
    • /
    • pp.23-36
    • /
    • 2020
  • Objective: This study was aimed to report the therapeutic effects of herbal medicine on chemotherapy-induced peripheral neuropathy (CIPN). Methods: The prior studies were searched from the databases included PubMed, Cochrane Library, EMBASE, CNKi, CiNii, KISS, NDSL, KMBASE, and OASIS until September 2020. The main search keywords were chemotherapy, peripheral neuropathy, and herbal medicine, and only randomized controlled trials that analyzed the therapeutic efficacy of herbal medicine were included. The Cochrane's Risk of Bias was used for assessment of the risk of bias and the Review Manager 5.3 program was used for meta-analysis. Meta-analyses were grouped by the administration routes of herbal medicines (oral administration or topical use). Results: Nine studies with a total of 563 participants were included. Compared with usual care, the effective rate was higher in oral administrated herbal medicine (RR 1.67, 95% CI 1.25 to 2.23; p<0.001, I2=31%). In addition, topical herbal medicine showed an significantly higher effective rate than placebo (RR 2.20, 95% CI 1.52 to 3.18; p<0.001, I2=0%) and usual care (RR 2.24, 95% CI 1.74 to 2.89; p<0.001, I2=66%). There was no severe adverse effect in all participants. Conclusions: Herbal medicine appears to improve neuropathy caused by chemotherapy in cancer patients more than conventional therapy of CIPN. However, as there is heterogeneity between the included studies and a lack of blinding, further well-designed researches are more needed.

A Case Report of Chemotherapy-Induced Peripheral Neuropathy Treated with Warm Needling (온침으로 호전된 항암화학요법 유발 말초신경병증 치험 1례)

  • Yoon, Jee-Hyun;Park, Su Bin;Lee, Jee Young;Kim, Eun Hye;Yoon, Seong Woo
    • The Journal of Internal Korean Medicine
    • /
    • v.42 no.2
    • /
    • pp.114-121
    • /
    • 2021
  • Objective: The purpose of this study is to report the effects of warm needling in a patient with cancer who had chemotherapy-induced peripheral neuropathy (CIPN). Methods: A 46-year-old Korean female outpatient diagnosed with malignant ovarian cancer was treated with warm needling therapy on the foot acupuncture points for CIPN. Neuropathic symptoms and quality of life were assessed using the numeric rating scale (NRS) and the functional assessment of cancer therapy/Gynecologic Oncology Group neurotoxicity (FACT/GOG-NTX) score. Results: After 6 months of treatment, the patient showed a reduction in the severity of CIPN symptoms and an improvement in the quality of life, although the severity of symptoms fluctuated as the patient underwent chemotherapy sessions. Conclusion: This study suggests that warm needling may be an effective treatment for CIPN.